132 related articles for article (PubMed ID: 22591319)
1. Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors.
Akyüz L; Sarıpınar E
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):776-91. PubMed ID: 22591319
[TBL] [Abstract][Full Text] [Related]
2. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
3. 4D-QSAR analysis and pharmacophore modeling: electron conformational-genetic algorithm approach for penicillins.
Yanmaz E; Sarıpınar E; Şahin K; Geçen N; Çopur F
Bioorg Med Chem; 2011 Apr; 19(7):2199-210. PubMed ID: 21419636
[TBL] [Abstract][Full Text] [Related]
4. 4D-QSAR study of HEPT derivatives by electron conformational-genetic algorithm method.
Akyüz L; Sarıpınar E; Kaya E; Yanmaz E
SAR QSAR Environ Res; 2012 Jul; 23(5-6):409-33. PubMed ID: 22452710
[TBL] [Abstract][Full Text] [Related]
5. 4D-QSAR investigation and pharmacophore identification of pyrrolo[2,1-c][1,4]benzodiazepines using electron conformational-genetic algorithm method.
Özalp A; Yavuz SÇ; Sabancı N; Çopur F; Kökbudak Z; Sarıpınar E
SAR QSAR Environ Res; 2016 Apr; 27(4):317-42. PubMed ID: 27121415
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method.
Saripinar E; Geçen N; Sahin K; Yanmaz E
Eur J Med Chem; 2010 Sep; 45(9):4157-68. PubMed ID: 20598401
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking studies on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1 NNRT inhibitors.
Sapre NS; Gupta S; Pancholi N; Sapre N
J Comput Aided Mol Des; 2008 Feb; 22(2):69-80. PubMed ID: 18163186
[TBL] [Abstract][Full Text] [Related]
8. Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors.
Sapre NS; Gupta S; Pancholi N; Sapre N
J Mol Model; 2008 Nov; 14(11):1009-21. PubMed ID: 18642033
[TBL] [Abstract][Full Text] [Related]
9. CoMFA 3D-QSAR analysis of HIV-1 RT nonnucleoside inhibitors, TIBO derivatives based on docking conformation and alignment.
Zhou Z; Madura JD
J Chem Inf Comput Sci; 2004; 44(6):2167-78. PubMed ID: 15554687
[TBL] [Abstract][Full Text] [Related]
10. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
[TBL] [Abstract][Full Text] [Related]
11. Relative free energy of binding and binding mode calculations of HIV-1 RT inhibitors based on dock-MM-PB/GS.
Zhou Z; Madura JD
Proteins; 2004 Nov; 57(3):493-503. PubMed ID: 15382241
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore Modelling and 4D-QSAR Study of Ruthenium(II) Arene Complexes as Anticancer Agents (Inhibitors) by Electron Conformational- Genetic Algorithm Method.
Yavuz SC; Sabanci N; Saripinar E
Curr Comput Aided Drug Des; 2018; 14(1):79-94. PubMed ID: 28554315
[TBL] [Abstract][Full Text] [Related]
13. QSAR modeling with the electrotopological state: TIBO derivatives.
Huuskonen J
J Chem Inf Comput Sci; 2001; 41(2):425-9. PubMed ID: 11277732
[TBL] [Abstract][Full Text] [Related]
14. Quantitative bioactivity prediction and pharmacophore identification for benzotriazine derivatives using the electron conformational-genetic algorithm in QSAR.
Sahin K; Sarıpınar E; Yanmaz E; Geçen N
SAR QSAR Environ Res; 2011 Jun; 22(3):217-38. PubMed ID: 21391137
[TBL] [Abstract][Full Text] [Related]
15. From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.
De Corte BL
J Med Chem; 2005 Mar; 48(6):1689-96. PubMed ID: 15771411
[No Abstract] [Full Text] [Related]
16. Quantitative structure-activity relationship studies on anti-HIV-1 TIBO derivatives as inhibitors of viral reverse transcriptase.
Gupta SP; Garg R
J Enzyme Inhib; 1996 Aug; 11(1):23-32. PubMed ID: 9204393
[TBL] [Abstract][Full Text] [Related]
17. Structural flexibility of non-nucleoside HIV-1 reverse transcriptase inhibitor: 9-Cl TIBO as explained by potential energy surface and (13)C and (1)H NMR calculations, based on ab initio and density functional study.
Saen-Oon S; Hannongbua S; Wolschann P
J Chem Inf Comput Sci; 2003; 43(5):1412-22. PubMed ID: 14502474
[TBL] [Abstract][Full Text] [Related]
18. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
Pungpo P; Hannongbua S; Wolschann P
Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
[TBL] [Abstract][Full Text] [Related]
19. The effect of stereoisomerism on the 4D-QSAR study of some dipeptidyl boron derivatives.
Çatalkaya S; Sabancı N; Yavuz SÇ; Sarıpınar E
Comput Biol Chem; 2020 Feb; 84():107190. PubMed ID: 31918171
[TBL] [Abstract][Full Text] [Related]
20. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
